Oric ' s stock rallies on multiple myeloma deal with Pfizer

Shares of Oric Pharmaceuticals Inc. ORIC, soared about 56% in premarket trading on Thursday, the day after the company said it will collaborate with Pfizer Inc. PFE, to develop a multiple myeloma therapeutic candidate. Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a…#spx #jeffsettleman #phase2 #pfe #pfizer #pfizerinc

Source: Reuters: Health - December 22, 2022 Category: Consumer Health News Source Type: news